2 enrolling by invitation. 2 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Enrolling by invitation 2 |
Follow Scleroderma, Systemic: new trials by email Literature Review of Scleroderma, Systemic trials Research Report on Scleroderma, Systemic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Universal CAR-T Cells (BRL-301) in Relapse or Refractory Autoimmune Diseases BRL-301 - Systemic Lupus Erythematosus (SLE), Sjogren's Syndrome | Not applicable | Enrolling by invitation | Bioray Laboratories | 15 | 2023-05-17 | 2024-11-20 |
| UVA-1 for Treatment of Skin Tightening and Improvement of Hand Function in Scleroderma UVA-1 Phototherapy - Scleroderma | Not applicable | Enrolling by invitation | University of Utah | 30 | 2020-12-12 | 2024-12-18 |
Antiphospholipid Syndrome (1) · Lupus Erythematosus, Systemic (1) · Myositis (1) · Scleroderma, Diffuse (1) · Sjogren's Syndrome (1)
Connective Tissue Diseases (2) · Skin Diseases (2) · Skin and Connective Tissue Diseases (2) · Arthritis (1) · Arthritis, Rheumatoid (1) · Autoimmune Diseases (1) · Dry Eye Syndromes (1) · Eye Diseases (1) · Immune System Diseases (1) · Joint Diseases (1) · Lacrimal Apparatus Diseases (1) · Mouth Diseases (1) · Muscular Diseases (1) · Musculoskeletal Diseases (1) · Nervous System Diseases (1)
Bioray Laboratories (1) · University of Utah (1)
China (1) · United States (1)